Drug Shortage Report for GLUCOPHAGE

Last updated on 2022-11-30 History
Report ID 165003
Drug Identification Number 02099233
Brand name GLUCOPHAGE
Common or Proper name Glucophage
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Bottle of 100 tablets
ATC code A10BA
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-07-19
Actual start date 2022-07-19
Estimated end date 2022-11-25
Actual end date 2022-11-14
Shortage status Resolved
Updated date 2022-11-30
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2022-11-30 French Compare
v16 2022-11-30 English Compare
v15 2022-11-11 French Compare
v14 2022-11-11 English Compare
v13 2022-10-28 French Compare
v12 2022-10-28 English Compare
v11 2022-09-27 French Compare
v10 2022-09-27 English Compare
v9 2022-09-13 French Compare
v8 2022-09-13 English Compare
v7 2022-08-18 French Compare
v6 2022-08-18 English Compare
v5 2022-08-11 French Compare
v4 2022-08-11 English Compare
v3 2022-07-20 English Compare
v2 2022-07-19 French Compare
v1 2022-07-19 English Compare

Showing 1 to 17 of 17